Kunihiko Ikeguchi

2.2k total citations
39 papers, 1.6k citations indexed

About

Kunihiko Ikeguchi is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Kunihiko Ikeguchi has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 14 papers in Neurology. Recurrent topics in Kunihiko Ikeguchi's work include Virus-based gene therapy research (12 papers), Nerve injury and regeneration (12 papers) and CRISPR and Genetic Engineering (8 papers). Kunihiko Ikeguchi is often cited by papers focused on Virus-based gene therapy research (12 papers), Nerve injury and regeneration (12 papers) and CRISPR and Genetic Engineering (8 papers). Kunihiko Ikeguchi collaborates with scholars based in Japan, France and United States. Kunihiko Ikeguchi's co-authors include Imaharu Nakano, Shin‐ichi Muramatsu, Keiya Ozawa, Ken’ichi Fujimoto, Hiroaki Mizukami, Toshiharu Nagatsu, Akihiro Kume, Masashi Urabe, Lijun Wang and Hiroshi Ichinose and has published in prestigious journals such as Journal of Neuroscience, Neurology and Molecular Therapy.

In The Last Decade

Kunihiko Ikeguchi

35 papers receiving 1.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kunihiko Ikeguchi 816 794 552 502 188 39 1.6k
Waldy San Sebastián 719 0.9× 532 0.7× 612 1.1× 236 0.5× 164 0.9× 35 1.4k
Lluı́s Samaranch 1.0k 1.3× 768 1.0× 700 1.3× 648 1.3× 214 1.1× 49 2.2k
Davide Mei 888 1.1× 482 0.6× 1.2k 2.1× 149 0.3× 75 0.4× 81 2.4k
Chengyong Shen 1.1k 1.3× 487 0.6× 124 0.2× 599 1.2× 171 0.9× 41 2.0k
Viviana Caputo 863 1.1× 439 0.6× 298 0.5× 643 1.3× 55 0.3× 52 1.8k
Rocío Ruiz 803 1.0× 466 0.6× 176 0.3× 120 0.2× 296 1.6× 51 1.5k
Maria Cristina D’Adamo 1.2k 1.5× 747 0.9× 162 0.3× 156 0.3× 66 0.4× 61 1.6k
James K. Kubilus 1.8k 2.2× 1.5k 1.9× 279 0.5× 604 1.2× 65 0.3× 18 2.4k
Allyson Cole-Strauss 920 1.1× 319 0.4× 280 0.5× 346 0.7× 38 0.2× 32 1.5k
Sharon Minnerath 989 1.2× 820 1.0× 353 0.6× 125 0.2× 88 0.5× 17 1.9k

Countries citing papers authored by Kunihiko Ikeguchi

Since Specialization
Citations

This map shows the geographic impact of Kunihiko Ikeguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunihiko Ikeguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunihiko Ikeguchi more than expected).

Fields of papers citing papers by Kunihiko Ikeguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunihiko Ikeguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunihiko Ikeguchi. The network helps show where Kunihiko Ikeguchi may publish in the future.

Co-authorship network of co-authors of Kunihiko Ikeguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Kunihiko Ikeguchi. A scholar is included among the top collaborators of Kunihiko Ikeguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunihiko Ikeguchi. Kunihiko Ikeguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sehara, Yoshihide, Ken’ichi Fujimoto, Kunihiko Ikeguchi, et al.. (2017). Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease. PubMed. 28(2). 74–79. 112 indexed citations
2.
Muramatsu, Shin‐ichi, Kenichi Fujimoto, Seiya Kato, et al.. (2010). A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease. Molecular Therapy. 18(9). 1731–1735. 255 indexed citations
3.
Li, Xiaogang, Takashi Okada, Naomi Takino, et al.. (2005). Viral-Mediated Temporally Controlled Dopamine Production in a Rat Model of Parkinson Disease. Molecular Therapy. 13(1). 160–166. 46 indexed citations
4.
5.
Muramatsu, Shin‐ichi, Lijun Wang, Kunihiko Ikeguchi, et al.. (2003). Gene Therapy with Virus Vectors for specific Disease of the Nervous System. International review of neurobiology. 55. 205–222. 3 indexed citations
6.
Lu, Yanyan, Lijun Wang, Shin‐ichi Muramatsu, et al.. (2002). Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport. Neuroscience Research. 45(1). 33–40. 53 indexed citations
7.
Muramatsu, Shin‐ichi, Lijun Wang, Kunihiko Ikeguchi, et al.. (2002). Recombinant adeno-associated viral vectors bring gene therapy for Parkinson's disease closer to reality. Journal of Neurology. 249(0). 1–1. 9 indexed citations
8.
Namekawa, Michito, Yoshihisa Takiyama, Kumi Sakoe, et al.. (2002). A Japanese SPG4 family with a novel missense mutation of theSPG4gene: intrafamilial variability in age at onset and clinical severity. Acta Neurologica Scandinavica. 106(6). 387–391. 8 indexed citations
9.
Wang, Lijun, Shin‐ichi Muramatsu, Yanyan Lu, et al.. (2002). Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Therapy. 9(6). 381–389. 122 indexed citations
10.
Kuriki, Ken, et al.. (2000). An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap. Neuropathology. 20(3). 233–238. 8 indexed citations
11.
Aoki, Yoshitsugu, Takahiko Saida, Imaharu Nakano, et al.. (2000). Determination of medullasin levels for the diagnosis of multiple sclerosis. Acta Neurologica Scandinavica. 102(4). 218–221.
12.
Ozawa, K, Yan‐Qin Shen, Shin‐ichi Muramatsu, et al.. (2000). Gene therapy of Parkinson’s disease using Adeno-Associated Virus (AAV) vectors. PubMed. 181–191. 17 indexed citations
13.
Mogi, Makio, Akifumi Togari, Matsuo Ogawa, et al.. (1998). Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1β and nerve growth factor in the striatum. Neuroscience Letters. 250(1). 25–28. 58 indexed citations
14.
Fan, Dongsheng, Matsuo Ogawa, Kunihiko Ikeguchi, et al.. (1998). Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro. Neuroscience Letters. 248(1). 61–64. 25 indexed citations
15.
16.
Ikeguchi, Kunihiko, et al.. (1995). Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs. European Archives of Psychiatry and Clinical Neuroscience. 244(6). 320–324. 47 indexed citations
17.
Koike, Ryoko, Osamu Onodera, Kiyotoshi Kaneko, et al.. (1995). Partial deletions of putative adrenoleukodystrophy (ALD) gene in Japanese ALD patients. Human Mutation. 6(3). 263–267. 7 indexed citations
18.
Ikeguchi, Kunihiko, et al.. (1995). Mianserin, a 5‐HT2receptor antagonist, in the treatment of delirium: an open study. European Journal of Neurology. 1(3). 261–266. 5 indexed citations
19.
Fujimoto, Ken’ichi, Kunihiko Ikeguchi, & Mitsuo Yoshida. (1992). Impaired acquisition, preserved retention and retrieval of avoidance behavior after destruction of pedunculopontine nucleus areas in the rat. Neuroscience Research. 13(1). 43–51. 42 indexed citations
20.
Fujimoto, Ken-ichi, Kunihiko Ikeguchi, & Mitsuo Yoshida. (1990). Decrease and recovery of choline acetyltransferase activity in medial thalamus and ventral tegmental area after destruction of pedunculopontine nucleus areas in the rat. Neuroscience Research. 9(1). 48–53. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Waldy San Sebastián Breakdown of academic impact, for papers by Lluı́s Samaranch Breakdown of academic impact, for papers by Davide Mei Breakdown of academic impact, for papers by Chengyong Shen Breakdown of academic impact, for papers by Viviana Caputo Breakdown of academic impact, for papers by Rocío Ruiz Breakdown of academic impact, for papers by Maria Cristina D’Adamo Breakdown of academic impact, for papers by James K. Kubilus Breakdown of academic impact, for papers by Allyson Cole-Strauss Breakdown of academic impact, for papers by Sharon Minnerath
Rankless by CCL
2026